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Microarrays and RNA-Seq identify molecular
mechanisms driving the end of nephron
production
Eric W Brunskill1, Hsiao L Lai2, D Curtis Jamison3, S Steven Potter1, Larry T Patterson2*
Abstract
Background: The production of nephrons suddenly ends in mice shortly after birth when the remaining cells of
the multi-potent progenitor mesenchyme begin to differentiate into nephrons. We exploited this terminal wave of
nephron production using both microarrays and RNA-Seq to serially evaluate gene transcript levels in the
progenitors. This strategy allowed us to define the changing gene expression states following induction and the
onset of differentiation after birth.
Results: Microarray and RNA-Seq studies of the progenitors detected a change in the expression profiles of several
classes of genes early after birth. One functional class, a class of genes associated with cellular proliferation, was
activated. Analysis of proliferation with a nucleotide analog demonstrated in vivo that entry into the S-phase of the
cell cycle preceded increases in transcript levels of genetic markers of differentiation. Microarrays and RNA-Seq also
detected the onset of expression of markers of differentiation within the population of progenitors prior to
detectable Six2 repression. Validation by in situ hybridization demonstrated that the markers were expressed in a
subset of Six2 expressing progenitors. Finally, the studies identified a third set of genes that provide indirect
evidence of an altered cellular microenvironment of the multi-potential progenitors after birth.
Conclusions: These results demonstrate that Six2 expression is not sufficient to suppress activation of genes
associated with growth and differentiation of nephrons. They also better define the sequence of events after
induction and suggest mechanisms contributing to the rapid end of nephron production after birth in mice.
Background
In humans, the final number of nephrons that are pro-
duced during the formation of the kidney is extremely
variable, ranging from 230,000 to 1,800,000 [1]. The
number has clinical relevance because a decrease in the
number has been associated with hypertension [2].
Although our knowledge about the molecular control of
nephron formation has grown substantially in recent
years, little is known about the mechanisms controlling
the final number.
During renal development, multi-potential progenitors
surround the branch tips of the ureteric bud. These
self-renewing progenitors are maintained in an
undifferentiated state at least in part by Six2 [3], and are
induced to differentiate into nephrons by Wnt9b [4]. In
mice and humans the lifespan of this population of pro-
genitors is limited providing a means to regulate the
final endowment of nephrons. Even though little is
known about the mechanism controlling the popula-
tion’s lifespan, it must be able to account for some
important differences between humans and mice at the
end of nephron production. In humans, for example,
branching morphogenesis of the ureteric bud ends early
at 22 weeks of gestation [5], whereas in mice it ends
within the three days after birth [6]. In humans,
nephron production extends twelve weeks beyond the
period of ureteric bud branching to 34 weeks gestation,
whereas in mice production ends around the same time
as branching morphogenesis ends, about three days after
birth [6]. Thus, the relationship of the completion of
these two processes, branching morphogenesis and
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nephron production, markedly differ in humans and
mice, suggesting the possibility of some small difference
in the mechanism controlling the completion of
nephron production.
To understand the molecular mechanisms that drive
the completion of nephron production in mice, we
defined the gene expression programs of the progeni-
tors of nephrons during the first four days after birth.
At this time, all remaining progenitors progress from a
primarily un-induced to an induced state, and then
form renal vesicles. This final wave of production offers
a unique opportunity to evaluate the progenitors
because of the near synchronous change in their beha-
vior. Our results indicate that induction, defined by
altered gene expression, occurs before significant
decreases in Six2. We also show that proliferation
increases prior to detectable increases in transcripts of
genes associated with differentiation. Further, we show
that expression of some genes, previously defined as
markers of later developmental stages, is present in
capping mesenchyme cells co-expressing Six2. Finally,
we observed altered expression levels of genes encod-
ing proteins in the glycolytic pathway, consistent with
a change in the microenvironment of the population of
progenitors after birth. The microarray results were
independently validated and expanded by using a next
generation deep sequencing RNA-Seq approach. The
resulting profiles better define the order of events and
the genes involved after induction of progenitors, as
nephron production comes to an end.
Results
We captured the green fluorescent protein (GFP)-
positive population of cells depicted in Figure 1 from
kidneys of Tg(Crym-EGFP)82Gsat/Mmcd mice at birth
(P0) and at post-natal days one through four (P1
through P4) by flow cytometry to analyze the levels of
gene transcripts. These cells are progenitors that form a
cap around the tips of branches of the ureteric bud.
Upon induction by the ureteric bud, they begin to dif-
ferentiate into renal vesicles. In the transgenic mice,
they express GFP in a pattern that reproduces Crym
expression [7]. It has been proposed that the cap can be
further subdivided into un-induced and induced
mesenchyme based on the expression of Cited1, with
the un-induced mesenchyme expressing Cited1 [8]. To
better define the population of cells that we would col-
lect by fluorescence activated cell sorting (FACS), we
stained the tissues with antibody to Cited1. Both popu-
lations, Cited1(+) and Cited1(-), expressed GFP at high
levels (See additional file 1a: Optical section of Tg
(Crym-EGFP)82Gsat/Mmcd transgenic mouse kidney).
The two different cell types were therefore indistin-
guishable by FACS based on the level of expression of
GFP and were captured together during cell-sorting.
GFP was also present in renal vesicles at birth and later
(See additional file 2: Optical section through transgenic
mouse kidney at P0, and Figure 1 P3, respectively),
albeit at significantly lower levels. The lower level in dif-
ferentiating cells made it possible to distinguish them
from capping mesenchyme by gating to GFP fluores-
cence intensity during cell-sorting. GFP was not
detected in the stromal mesenchyme between the caps
or in the branch tips of the ureteric bud (See additional
file 1). The most striking change in character of the cap
was seen between P2 and P3 (See additional file 1b) as
Cited1 expression turned off leaving only scattered
patches of staining at P3. As presented in the discussion,
the progenitors on P2 likely represent induced mesench-
yme even though they still express Cited1.
Figure 1 EGFP expression is limited to the capping mesenchyme and to early stage nephrons after birth, and demonstrates an abrupt
change in morphology of the cap. GFP is expressed in the nephron progenitor mesenchyme of transgenic mice at birth and at lower levels in
newly induce nephrons. The GFP signal in the mesenchyme at birth (P0) surrounds the branch tips of the ureteric bud which are unlabeled. The
pattern changes very little until post-natal day 3 (P3) when the crescent-shaped mesenchyme begins to be replaced by renal vesicles, ovoid
structures with central cavities (arrows). The images are 2 micron thick optical sections taken by a laser scanning microscope on a plane parallel
to the tangent of the kidney surface through the cortical nephrogenic zone. The gain was increased at P3 to allow visualization of the reduced
levels of GFP expression. The intensities between panels cannot be directly compared.
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The difference in the level of expression of GFP
between capping mesenchyme and the renal vesicles
allowed us to collect cells of the cap at birth, P1, and
P2, and the developing renal vesicles at P3 and P4. We
have shown that the multi-potential progenitors, which
form the cap and express Cited1, disappear by three
days of age in the mouse, and that nephron production
ceases at that time [6]. Thus, the cells that are captured
at the later times are no longer considered self-renewing
progenitors. By gating the FAC sorting to collect only
the most highly expressing GFP-positive cells at each
time (See additional file 3: Image of the FACS plot of
cells collected for RNA measurements:), we could
exploit this phase of development to determine the
changing gene expression states during induction
and early differentiation. The sudden loss of the high-
expressing, un-induced mesenchyme after birth and the
continued lower-level expression of GFP in the early
developing nephron made it possible to collect a series
of samples beginning with the un-induced progenitors,
then induced progenitors, and finally cells in the early
stages of differentiation. This period after birth, which
contrasts the embryonic period when the dominant
population of GFP-positive cells is un-induced, permits
an enriched population of recently induced cells to be
isolated.
We used a series of microarrays to measure transcript
levels in GFP-positive cells from post-natal kidneys.
Using ANOVA with Benjamini-Hochberg correction for
multiple testing, we identified over 2000 genes with
changing levels of expression (p < 0.05) during the four
days after birth (See additional file 4: List of genes with
changing levels of expression by microarray after birth).
This is the most comprehensive list of genes that change
in the span between un-induced mesenchyme and renal
vesicle. The stepwise sequence in which the genes are
activated or inactivated can be easily tracked. For
instance, Cited1 expression remained high through P2
before precipitously falling (Figure 2b and See additional
file 4), consistent with the expression of Cited1 by
immunohistochemistry (See additional file 1b).
Taking advantage of the series of arrays, we next exam-
ined a subset of developmental times to detect genes
showing very early changes in transcript levels, repre-
senting the initial response to either induction or to the
extra-uterine environment. By comparing P0 samples
with P2 using unpaired t-test, we identified 70 genes
(p < 0.05) with at least a 1.5-fold change (Figure 2a).
Fifty genes were more highly expressed in the GFP(+)
cells at birth than at P2 and included Tgfbi, Dock5,
Robo2, and Mfap4. The expression patterns of these
four genes in the cap have historic validation in the
embryonic kidney by in situ hybridization [7]. Expres-
sion was down regulated earlier than a significant down-
regulation in expression of Cited1 (Figure 2b.), a gene
that has been used to mark un-induced cells. The
expression of this marker decreased by P2, but it
decreased an additional four- to five-fold in the subse-
quent two days. The genes we identified therefore repre-
sent a very early response after birth.
Twenty genes were more highly expressed in the cap
at P2 than at P0. They included Cdh6, Bmp2, Ccnd1,
Pax8, Hey1, Lhx1, Npy, and Jag1. They too have histori-
cally validated embryonic expression, but in the early
stage nephrons, rather than in the mesenchyme. Arrays
also identified developmental control genes, such as
Rspo3, a secreted regulator of beta-catenin signaling [9],
and Fat3 (see discussion), two genes that have not been
studied during renal development. It is interesting to
note at P2, when capping mesenchyme is still abundant,
that many of the genes showing higher expression com-
pared to P0 are reported in the literature to be asso-
ciated with more advanced stages of differentiation and
not with the mesenchyme. These results could represent
either contamination with differentiated cells or low-
level expression of vesicle genes in the induced cap
prior to vesicle formation.
In situ hybridization expression
Basing our choices on the microarray results, we
selected genes with changing levels of expression to
validate their patterns of expression and to address the
question of possible contamination. To microscopically
localize the expression, we used dual-label fluorescent
whole mount in situ hybridization. This method pro-
vides better localization than other in situ protocols
because the fluorochrome is covalently bound to tis-
sues at the site of hybridization. It also permits co-
localization of expression because confocal imaging can
determine expression of genes in thin optical sections.
As expected, the expression signals of those genes
with higher levels at P0 than P2 by microarray were
detected in the cap and not in developing nephrons
(Fat3 and Tgfbi, Figure 3). Some genes (Bmp2, Clu,
and Lama4) having higher expression at P2 rather than
P0 were also expressed in the mesenchyme, but the
expression was more restricted. The signal co-localized
with a cap marker, Six2, only at the ends of the cres-
cent-shaped cap (Figure 3), in the region of the defini-
tively induced Cited1(-) cells. The results of the
microarrays were therefore validated and not an arti-
fact of contamination by differentiated cells. Nephron
anlage did not underlie these areas, indicating that the
observed cap mesenchyme expression was genuine and
not the result of spillover from adjacent regions as
well. These genes were also highly expressed in devel-
oping nephrons as were other genes that were similarly
up regulated by P2.
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Figure 2 Heatmap of genes showing significant changes in levels of expression between the progenitor mesenchyme at birth and the
mesenchyme at day 2 of life. Fifteen microarrays, three daily from birth (P0) to post-natal day 4 (P4), were used to define the progression of
gene expression in the mouse kidney beginning with the multi-potential progenitor mesenchyme and continuing through induced
mesenchyme to early renal vesicles. a) The expression level of twenty genes increased between P0 and P2, whereas the level decreased for fifty
genes (blue signifies low, yellow intermediate, and red high levels of expression). The pattern over the entire 4-day period is shown with each
column representing the expression levels of a single microarray. Hierarchical clustering divides the genes into groups with similar expression
patterns. For example, three genes, Tpi1, Aldoa, and Pfkl, are part of a cluster towards the bottom of the figure. Their levels of expression
decreased early, decreasing by P1, and then remained stable through P4. Other clusters of genes with decreasing levels show a continued
decrease, or did not demonstrate a decrease until P2. b) For comparison, the heatmap shows the pattern of expression of genes commonly
identified with capping mesenchyme. The patterns illustrate changing levels of expression later in the course after birth.
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Figure 3 Dual-label fluorescent whole mount in situ hybridization studies showed the expression patterns of a set of genes which
have a changing level of expression after birth. Tgfbi and Fat3 were expressed in the nephron progenitor mesenchyme (red signal)
surrounding ureteric bud branch tips (blue - Wnt11 riboprobe) at P2. Bmp2, Clu, and Lama4 (red) were expressed in the nephron anlage, and
were also co-expressed (arrows) with Six2 (blue) in capping mesenchyme. Selected regions of capping mesenchyme are outlined with a white
line. Bars = 100 microns.
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RNA-Seq
We also used RNA-Seq to independently measure differ-
ences in gene expression between progenitors at P0 and
P2. Deep sequencing of cDNA libraries lacks the bias
related to microarrays, and it can be used to digitally
quantify gene expression, even at the exon level, over a
wide dynamic range. We aligned the sequences to the
mm9 mouse sequence database. This is a subset of Ref-
seq, which is an integrated, non-redundant database of
linked nucleotide and protein sequences. The total num-
ber of single-end sequence reads from P0 and P2 was
3.1 and 3.3 million reads, respectively. Alignment with
mitochondrial sequences gave an additional 0.65
and 0.4 million reads, respectively. Reads aligned to
19,168 mouse genes and counts ranged from 1 to almost
150,000. Interestingly, and providing a measure of the
quality of the analysis, we found that the percent
decrease (37%) in expression of GFP at P2 was similar
to the decrease (49%) in expression of Crym, the gene
controlling GFP expression.
The RNA-Seq data provided independent high
throughput validation of the microarray results. Ninety
percent of the genes called at least 1.5 fold differentially
expressed between P0 and P2 by microarrays were con-
firmed by RNA-Seq (Figure 4). Indeed, even with the
modest number of sequence reads generated in this
study, RNA-Seq found more gene expression differences
than microarrays. Analysis with Partek Genomic Suite
showed, after Bonferroni correction, that over 300 genes
differed significantly in levels of expression at the two
times (See additional file 5: List of genes with a change
in level of expression by RNA-Seq between P0 and P2).
Of these, 64% changed by 1.5-fold or more. In fact, it
identified a significant decrease in expression of Cited1
by P2 (See Table 1), a decrease that was not discovered
by microarray.
We examined the RNA-Seq data to identify classes of
genes that were activated early after birth during the
induction of progenitors. We identified a strong signature
of cell proliferation (Rrm2, Vrk1, Mycn, Cenpm, Chaf1b,
Uhrf1, Fen1, Psat1, Plekhg6, Ccnd1, and Usp10). This
suggested that activation of the cell cycle was an early
response to induction. We then examined cell prolifera-
tion in detail using EdU nucleoside analog incorporation
and found a marked difference between P1 and P2 in the
distribution of cells entering S-phase (Figure 5). At P1
large patches of capping mesenchyme were devoid of
cells incorporating EdU. At the same time incorporation
was seen in ureteric bud branch tips, in the stromal
mesenchyme, and in some areas of cap, indicating pene-
tration of the label into all structures, and serving as a
positive control. A day later, at P2, cells incorporating
EdU appeared randomly scattered throughout the cap-
ping mesenchyme, occupying the regions where incor-
poration had been absent. The number of EdU(+) cells
increased from 3800 cells/mm2 surface area of the cap-
ping mesenchyme at P1 to 5900 cells/mm2 at P2. The
increase in number of cells incorporating EdU not only
preceded structural changes associated with differentia-
tion, but also seemed to precede the onset of expression
of the earliest genes associated with differentiation. At
this time the only detectable evidence of activation of
genetic markers associated with differentiation appears is
at the ends of the crescent-shaped caps (Figure 3). Thus,
the studies better define a sequence of events after induc-
tion in vivo. Consistent with expression of genes asso-
ciated with proliferation, we also found a significant
change in expression of genes with putative transcription
factor binding sites for E2F, a regulator of proliferation
[10] (Figure 6 and See additional file 6: Functional sets of
genes with a change in level by RNA-Seq between P0
Figure 4 Scatter plot of the RNA-Seq expression data
demonstrates that most of the microarray-defined genes with
changing levels of expression (bold) have a concordant change
by RNA-Seq. The plot is on a log2 transformed scale.
Table 1 RNA-Seq reads at P0 and P2 for genes expressed
during renal development
P0 (RPKM) P2 (RPKM) Significance
Genes
Cited1 735 350 P < 10-93
Crym 5451 2791 P < 10-200
Gdnf 9 7 NS
Itga6 7 8 NS
Six2 3 2 NS
Wnt4 1 16 NS
Wt1 2 2 NS
RPKM - Reads per kilobase per million sequences - normalization to the total
number of reads.
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and P2). Finally, we found that levels of transcripts for
multiple ribosomal proteins changed, suggesting global
changes in levels of protein synthesis.
P1-P4 gene expression differences
A comparison of the P1 to P4 gene expression profiles
identified changes occurring with further differentiation
of the cap mesenchyme into renal vesicles. A fairly strin-
gent screen (paired t-test P < 0.05, including Benjamini-
Hochberg correction, and a fold change > 2) found 227
significantly up-regulated and 206 significantly down-
regulated genes (See additional file 7: List of genes with
changes in transcript levels between P1 and P4). Topp-
Gene analysis of the up-regulated genes identified mole-
cular functions and biological processes including
calcium ion binding, ephrin receptor binding, sphingoli-
pid binding, cell adhesion, and epithelium development.
In addition, the analysis identified a number of candi-
date downstream targets of Wnt signaling, as defined by
the presence of evolutionarily conserved Lef transcrip-
tion factor binding sites in proximal promoter regions
(Figure 7 and See additional file 8: Functional sets of
genes with transcript levels that decrease or increase
between P1 and P4).
Glycolysis in progenitors
Of interest, in our analysis of the microarray data we
found that eight genes encoding enzymes in the glycoly-
tic pathway had a significantly reduced level of expres-
sion (P < 0.05) at P2 compared to P0. Five of these were
down regulated at least 1.5 fold (Pfkl, Aldoa, Tpi1, Eno3
and Pdk1). Three of these genes (Pfkl, Aldoa, and Tpi1)
clustered together (Figure 2), indicating similar
expression patterns after birth. The pattern of change
was evident by 24 hours after birth. The change pre-
ceded the increase in Wnt4 levels, a marker of renal
vesicles, and preceded the decrease in Cited1 levels (Fig-
ure 2 and See additional file 4). RNA-Seq validated this
decrease in level of expression of seven genes (Gpi1,
Pfkl, Aldoa, Tpi1, Eno3, Pkm2, and Pdk1). In contrast,
the level of expression of genes encoding enzymes of
the Kreb’s cycle (Aco2, Idh2, Ogdh, Scla2, Sdha, Fh1,
and Mdh1) remained constant in the interval between
P0 and P2 by both microarray and RNA-Seq. We ana-
lyzed microarray data from the GUDMAP consortium
[11] to identify changes in expression of glycolysis genes
during the process of differentiation of cap mesenchyme
in the embryo. When we compared the cap mesench-
yme expression of E15.5 embryos to renal vesicles of
E12.5 embryos, we could not detect similar changes in
expression of the glycolysis genes.
Discussion
The genome-wide evaluation of the multi-potent pro-
genitor cell mesenchyme and early stage nephron tran-
scriptome after birth showed sequential activation or
inactivation of many genes. The use of tissue after birth
to obtain expression data eliminates potential artifacts
introduced during in vitro studies of sequential activation
after induction. The period after birth allows serial mea-
surements of transcripts early after induction because
there is such an abrupt change in the behavior of the pro-
genitors. By P3 all remaining capping mesenchyme has
begun conversion into renal vesicles. Because the induc-
tive period and the time to show signs of differentiation
after induction each take 12-24 hours (reviewed in Saxen
[12]), the final wave of induction to form nephrons had
begun by P2. This strongly suggests, therefore, that the
Cited1(+) cells at P2, which still constitute most of the
GFP(+) capping mesenchyme (See additional file 1), were
likely to have been induced and to be different from the
capping mesenchyme on P0 and P1 when the bulk of the
high GFP expressing cells was un-induced. There is
clearly a progression of molecular events post-induction,
with the down-regulation of Cited1 corresponding to a
more advanced state of induction or possibly a state of
commitment.
Our results confirmed differences in expression level
between capping mesenchyme and renal vesicle found
among a series of markers previously reported by Mug-
ford et.al. [8]. Seven of the nine markers, which distin-
guished between progenitor cell mesenchyme and
vesicles by in situ (Cited1, Bbx, Eya1, Osr1, Six2, Dpf3,
and Meox1), showed greater than a 2-fold change in
level of expression between P0 and P4. The trend was
correct for the remaining two markers (Hoxc5 and
Brpf1), but did not reach a 2-fold change in level. Our
Figure 5 Cell cycle S-phase labeling by nucleoside analog
incorporation with EdU (green) showed a higher rate of cell
proliferation in the capping mesenchyme at P2 than at P1. At
P2 the cap surrounding ureteric bud branch tips (blue - E-cadherin)
contained many more cells which incorporated the label. The
optical sections at P1 and P2 were obtained at the same level
relative to the branch tip of the ureteric bud, just superficial to the
central lumen in the branch tips of the ureteric bud. Bar = 50
microns.
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data extend this list significantly by adding more than
400 genes that change in level between P0, when
mesenchyme is abundant, and P4, when GFP primarily
marks renal vesicles. This provides a significant resource
that can be used when monitoring induction of the
mesenchyme.
Discovery of genes that have a spatially restricted pat-
tern of expression during the process of differentiation
helps to identify pathways that may be needed for
nephron formation. We found that Fat3 was expressed
in the cap at P0 and was down regulated by P2. The Fat
genes encode cadherin-type proteins with cell-cell adhe-
sion properties. With mutation of Fat genes in
Drosophila, there is overgrowth of tissues [13]. It is
interesting in Drosophila that Fat is part of a pathway
involved in the suppression of wingless, a homolog of a
murine gene (Wnt4) that is expressed after mesenchy-
mal induction and is required for nephron development
[14]. This suggests that the down-regulation of Fat3
may be needed before activation of Wnt4 in the induced
mesenchyme.
We also identified early up-regulated expression of
genes in several different pathways and examined them
by in situ hybridization. One gene, Bmp2, was activated
early in the induced capping mesenchyme next to one
side of the ureteric bud branch tips. The secreted
Figure 6 ToppGene functional analysis of genes changing in expression between P0 and P2. Green boxes indicate biological processes
(dark) and molecular functions (light) with gray lines indicating connections to associated genes (hexagons). V$SRF_C (purple) and V$E2F_03
(yellow) boxes are transcription factor binding sites evolutionarily conserved in the promoter regions of multiple genes. Candidate targets of E2F
are shown in yellow. Complete lists of molecular functions, biological processes, and transcriptional factor binding sites and associated genes are
in Additional file 6.
Brunskill et al. BMC Developmental Biology 2011, 11:15
http://www.biomedcentral.com/1471-213X/11/15
Page 8 of 12
Figure 7 ToppGene functional analysis of genes elevated in expression between P1 and P4. Green boxes indicate biological processes
(dark) and molecular functions (light) with gray lines indicating connections to associated genes (hexagons). Highly enriched, evolutionarily
conserved transcription factor binding sites, V$TEF_6 (purple) and CTTTGA_V$LEF1_Q2 (yellow) are shown, with candidate Wnt (Lef1) target
genes (yellow hexagons). Complete lists of biological functions, molecular functions, and transcription factor binding sites are found in
Additional file 8.
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protein encoded by Bmp2 is known to regulate both the
branching of the ureteric bud tips and the proliferation
of their cells [15]. With the localized expression, Bmp2
may regulate the regional growth of cells within the tips.
Its expression is also of interest because along with Clu
and Lama4 it is activated in the induced cap before
morphologic changes are evident. It seems reasonable
that capping mesenchymal cells initiating renal vesicle
formation would begin expressing genes associated with
renal vesicles, although to our knowledge this has not
been previously demonstrated.
It is interesting that these induced genes, which are
associated with differentiation, are co-expressed with
Six2. Six2 is necessary to maintain the population of
multi-potential progenitors; however, it has not been
shown to be sufficient. The co-expression of genes
involved in differentiation in a subset of Six2 (+) cells
suggests that Six2 is not sufficient to block transcription
of some genes associated with differentiation in the pre-
sence of an inductive signal.
We also observed an interesting surge in cell prolif-
eration that preceded the expression of markers of dif-
ferentiation. The sequence of events suggests the
possibility that proliferation promotes the reprogram-
ming of renal progenitors. This type of mechanism has
been described during reprogramming of somatic cells
into pluri-potent stem cells [16]. An increase by P2 in
proliferation, evidence of a change in the behavior of
progenitors, is also consistent with induction of the
cells by P2.
Also of note, the gene expression profiles of early
forming nephrons differed before and after birth. The
genes included those encoding enzymes of the glycolytic
pathway. The shift in transcription is compatible with a
response by the population of progenitors to a change
in the microenvironment, such as a post-natal increase
in oxygen levels. Prior to birth the kidney is fed by
deoxygenated blood, blood with the same oxygen con-
tent as that returning to the placenta. In addition, oxy-
gen delivery to the nephrogenic region is further limited
because the tissue is relatively avascular. Relative physio-
logic hypoxia, such as this, is known to cause an
increase in transcription of genes encoding enzymes of
the glycolytic pathway [17]. Changes in levels of expres-
sion of other genes that are regulated in an oxygen-
dependent manner, such as P4ha1, Bnip3L, and Txnip,
provide further supportive evidence of an increase in
oxygenation in the progenitors after birth.
Cellular fates of placental cytotrophoblasts [18], hema-
topoietic progenitors [19], human neural stem cells [20],
bone marrow stromal cells [21], and human embryonic
stem cells [22] have been shown to be altered by oxygen.
The fate of murine embryonic stem cells also appears to
be coupled to metabolism [23]. It seems reasonable,
therefore, to speculate that a change in the microenviron-
ment, such as a change in oxygenation within the physio-
logic range, might also lead to a change in behavior of
the multi-potential progenitors in the kidney in vivo.
Lastly, the final nephron endowment is clearly a result
of regulation of the balance between the rate of progeni-
tor renewal and the rate of differentiation. Simple geo-
metry might play an important role in the balance in
both mice and humans. In the early kidney, the capping
mesenchyme layer is relatively thick. As branching mor-
phogenesis proceeds, the number of branch tips will
expand geometrically, subdividing the capping mesench-
yme while also inducing it. Unless renewal of the pro-
genitors similarly expands, the cap around each tip will
thin. And, at some point it will no longer be able to
promote further branching. After branching ends, if
usage of cells to make nephrons exceeds the renewal
rate, nephron production will consume the remaining
cap mesenchyme. In humans this simple model fits
nicely with the completion of nephron production
because there is a prolonged period of nephron produc-
tion without branching. In the mouse, however, there is
an abrupt end to both nephron production and branch-
ing morphogenesis. The end coincides with birth and
with a change in metabolism that is compatible with an
increase in oxygenation of the progenitors. Coupled
with the known effects of oxygen on cellular fate, the
events suggest a possible trigger in mice at birth that
shifts the balance between renewal and differentiation of
progenitors favoring differentiation. We speculate that
the trigger then limits the lifespan of the population of
progenitors and causes the production of nephrons in
mice to end abruptly.
Conclusions
In this study we used microarrays, RNA-Seq, in situ
hybridization, and EdU nucleotide incorporation to
examine the synchronous wave of nephron formation
that occurs in mouse following birth. The results pro-
vide a global definition of the changing gene expression
program that drives the transition from un-induced cap-
ping mesenchyme, to induced capping mesenchyme,
and to renal vesicle. Several genes were found to change
in expression before Cited1 was down regulated, sug-
gesting a further molecular subdivision of induced
capping mesenchyme. We also observed that cell prolif-
eration preceded differentiation. Further, we observed
the expression of renal vesicle associated genes, includ-
ing Bmp2, within the Cited1(-), but Six2(+), region of
the capping mesenchyme. This demonstrates that Six2
at the normal level of expression alone is not sufficient
to block differentiation. Finally, genes essential for gly-
colysis were down regulated post-birth, compatible with
an increase in levels of oxygen within the capping
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mesenchyme domain. Given the known influence of
oxygen on the fate of cells this finding suggests a possi-




Tg(Crym-EGFP)82Gsat/Mmcd mice with GFP expres-
sion in nephron progenitors were used. To obtain
developmentally uniform tissue, mice were housed in
standard light-dark cycles, matings were started at
midnight, and mice checked for vaginal plugs eight
hours later. At noon on day 18 (e18.5) embryos were
delivered by Caesarian section, resuscitated, and placed
with a foster mother. Each litter of pups was used to
obtain kidneys for multiple post-natal samples. Kidneys
were dissected at birth (P0) and at 24-hour intervals
afterwards (P1-P4). We used CD-1 mice for in situ
hybridization and nucleotide analog incorporation. The
use of experimental animals described in this study
complies with the guidelines of the Institutional Ani-
mal Care and Use Committee at Cincinnati Children’s
Hospital.
Mesenchyme isolation
Two pairs of kidneys were isolated for each sample and
three samples isolated for each time. The kidneys were
digested in 0.05% Trypsin - EDTA for 15 minutes at 37°C,
treated with 2% FBS, and mechanically disaggregated at
4°C. The suspension of cells was filtered through a 70-
micron filter and separated using a BD FACS Aria II Cell
Sorter to collect GFP (+) cells with the highest fluores-
cence intensity (See additional file 3: Image of the FACS
plot of cells collected for RNA measurements).
Microarray and data analysis
Fifteen samples, three for each age, were isolated by cell
sorting and collected in RLT (Qiagen, CA). 5 ng of total
RNA was used with the NuGen WT-Pico, Exon Module,
and Fl-Ovation v.2 kits to generate target. 2.5 μg of target
was hybridized to Affymetrix Mouse Gene 1.0 ST arrays.
The data was deposited in the Gene Expression Omnibus
database (GSM429020-GSM429034). Analysis was per-
formed using GeneSpring GX and RMA normalization.
COMBAT software was used to correct for batch effect
[24]. ToppGene Suite was used to analyze gene lists to
identify functional groups of genes [11]. Cytoscape was
used to create Figure 6 and 7. To compare post-natal
changes in expression of glycolysis genes during differen-
tiation of progenitors to changes in the embryo we ana-
lyzed microarray data from the GUDMAP consortium
which had been deposited in the Gene Expression Omni-
bus (GEO, GSE12588 and GSE6290 datasets).
In situ hybridization
A dual-labeled fluorescent whole mount in situ hybridi-
zation procedure was used with confocal microscopy to
validate microarray results. Digoxigenin- or fluorescein-
labeled riboprobes were made for each of the test genes
(Clu, Fat3, Lama4, Tgfbi, Bmp2) and for both of the
reference genes (Wnt11 and Six2). Perkin Elmer tyra-
mide signal amplification and the Zeiss LSM 510 micro-
scope were used to detect the hybridization signal.
A series of 2-micron thick optical sections were
obtained beginning at the surface and extending into
the kidney at 5 micron intervals.
RNA-Seq and analysis
We collected GFP-positive progenitors by fluorescence
activated cell sorting, purified the RNA, and synthesized
cDNA from 150 ng of pooled RNA from each time, P0
and P2, using the Clontech SMART cDNA synthesis kit.
cDNA was then amplified using Stratagene Herculase
polymerase during a 24-cycle PCR reaction. The PCR
products were purified and treated with the BAL-31
nuclease to remove the SMART cDNA primer end, and
sequenced using the Illumina Genome Analyzer II stan-
dard 36-cycle paired-end protocol. Sequences were
aligned to the mus musculus (mm9 sequence database)
subset of RefSeq [25] in an unpaired alignment using
the ELAND [26]. The alignment could contain only two
mismatches of a 32 bp read to be included in the data-
sets. GeneSpring was used to graphically present the
raw RNA-Seq data and Partek Genomic Suites for statis-
tical analysis.
Cell cycle labeling
We used the Invitrogen Click-iT EdU Alexa Fluor 488
to label cells in S-phase of the cell cycle. Pups were
injected with EdU, a nucleotide analog, at 24 or at
48 hours of age. The kidneys from pups were excised
60-90 min later, fixed, and immunostained with antibo-
dies to E-cadherin as described before [6]. After block-
ing in 3% BSA in PBS, and washing in 0.1 M sodium
phosphate buffer pH 8, they were incubated in complete
Click-iT reaction buffer for 90 min at room tempera-
ture, washed and imaged by confocal microscopy.
Additional material
Additional file 1: Optical section of Tg(Crym-EGFP)82Gsat/Mmcd
transgenic mouse kidney. a) Strong GFP expression is seen in both the
Cited1(+) (red) and Cited1(-) (arrows) capping mesenchyme at P2 in the
Tg(Crym-EGFP)82Gsat/Mmcd mouse. GFP (green) is seen in the cap
surrounding the branch tips of the ureteric bud and does not extend
into the stroma. Ecadherin (blue); b) The abrupt change in character of
the cap between P2 and P3 is accompanied by loss of Cited1
immunostaining.
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Additional file 2: Optical section through transgenic mouse kidney
at P0. GFP is expressed at birth at lower intensity in the renal vesicles of
the Tg(Crym-EGFP)82Gsat/Mmcd mouse than in the capping
mesenchyme. The optical section through the nephrogenic region
shows a portion of a renal vesicle (encircled), defined by morphological
criteria of a central cavity in a deeper plane.
Additional file 3: Image of the FACS plot of cells collected for RNA
measurements. The GFP-positive cells with the highest level of
expression were collected by FACS. Gating was set at a constant level as
seen from birth to P3. After birth, both the fraction of GFP cells and the
level of GFP intensity (peak shifts to the left) decreased.
Additional file 4: List of genes with changing levels of expression
by microarray after birth. Relative expression levels of 2000 genes with
significant change in level of expression by ANOVA in the multi-potential
progenitors after birth in mice. Levels of expression obtained in triplicate
at birth (P0) and each 24-hour interval afterwards (P1-P4) were
combined. The data is Log2 transformed.
Additional file 5: List of genes with a change in level of expression
by RNA-Seq between P0 and P2. RNA-Seq raw counts, normalized
counts, fold change, and level of significance are shown for those genes
with a significant difference in expression between P0 and P2.
Additional file 6: Functional sets of genes with a change in level by
RNA-Seq between P0 and P2. Genes identified by Partek Genomic
Suites to significantly change were analyzed by ToppGene to identify
functional classes.
Additional file 7: List of genes with changes in transcript levels
between P1 and P4. List of genes identified by GeneSpring analysis of
microarrays.
Additional file 8: Functional sets of genes with transcript levels that
decrease or increase between P1 and P4. Genes identified by
GeneSpring to significantly change were analyzed by ToppGene to
identify functional classes.
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